duced sarcoma (MC-D) 
Introduction
While it is now generally recognized that malignant cells possess specific tumor antigens (TA), painstaking attempts in many laboratories to isolate TA and to produce anti-TA antibodies in significant quantities for further immunochemical manipulations have met with little success. In a number of investigations (Spar et al., 1964; Day, 1965; McCardle et al., 1966) 
deposition of fibrin
Reprint requests shouM be adressed to: A. H. Sehon in a wide variety of animal and human tumors has been noted, suggesting that fibrin is an important supporting lattice for tumor growth. These observations gave rise to the working hypothesis underlying this investigation, i.e., that tumor cells could be destroyed by an indirect cell-mediated immune response involving 'killer' lymphocytes from syngeneic donors sensitized not against the specific tumor antigens, but against (1) antigens normally present on or artificially coupled to antitumor antibodies capable of coating the tumor cells, or (2) antigens of xenogeneic antibodies directed against the unique antigenic determinants of the fibrin of the tumorbearing host.
In previous studies (Fujimoto et al., 1973; Lee et al., 1978) pure rabbit and goat IgG antibodies specific for the antigenic determinants of guinea-pig fibrin (i.e., freed of antibodies reacting with fibrinogen and other plasma components) were isolated with the aid of appropriate immunosorbents. On injection of these anti-guinea pig fibrin antibodies (AGFA) into strain 13 guinea-pigs (Gp 13) bearing the transplantable methylcholanthreneinduced sarcoma (MC-D), it was shown that these antibodies were localized at a considerably higher concentration in tumor tissue than in other organs. The experiments reported here represent the extension of this study, which was designed to establish whether the MC-D tumor growing within a fibrin matrix could be destroyed in vivo with cells from syngeneic guinea-pigs sensitized to a state of cell-mediated immunity (CMI) against immunoglobulins isotypic with the heterologous AGFA, i.e., to rabbit or goat IgG. Clearly, this experimental model is based on the assumption that (1) cells sensitized to immunoglobulins isotypic with AGFA would home onto the fibrin matrix, which would have been coated in vivo with AGFA, and (2) interaction between these sensitized cells and AGFA within the tumor site would lead to a local inflammatory reaction resulting in the release of cytotoxic and chemotactic factors that would annihilate the malignant cells within the fi-196 F. H. Lee et al.: Use of Antifibrin Antibodies for Destruction of Tumor Cells. II brin matrix, either b y t h e m s e l v e s or in c o n j u n c t i o n with o t h e r cells o f the host, w h i c h would be recruited to the t u m o r site.
Different doses of the sensitized cells (105, 106, 107, 10 s, 109) were transferred intravenously to normal Gp 13, and 72 h later the animals were challenged by intradermal injection of 20 ~g rabbit or goat IgG, after which the skin reactions were read as described above.
Materials and Methods

Animals, Tumor and AGFA
Details relating to these items were given in the preceding paper (Lee et al., 1978) . The animals used in this experiment were adult Gp 13 of both sexes, weighing 400-500 g. Rabbit and goat AGFA were used in this study. The lethal dose of MC-D cells in Gp 13 was 10s; in this study the animals received 106 MC-D cells and died 50-60 days after tumor implantation.
Elicitation of CMI in Guinea-Pigs to Xenogeneic IgG
In order to induce sensitized cells in Gp 13 to xenogeneic IgG, 80 ~g doses of rabbit or goat IgG emulsified in Freund's complete adjuvant (FCA) were injected into the footpads of guinea-pigs. The IgGs were isolated from the corresponding normal sera by column chromatography on DEAE-cellulose, phosphate buffers pH 8.0 (0.01 M for rabbit IgG and 0.02 M for goat IgG) being used for elution. The following in vivo and in vitro tests were used to establish the development of sensitized lymphoid cells to xenogeneic IgG.
Skin Tests. To ascertain whether sensitized cells had been induced in immunized animals, they were challenged intradermally 2 weeks after sensitization with several doses of the immunizing antigen (10, 20, and 30 p~g in 0.1 ml), and 48 h later the diameters of the skin reactions were measured with a vernier caliper. Only skin reactions with diameters larger than 10 mm were considered positive.
Passive Transfer of Delayed Hypersensitivity. The ability of lymphoid cells from immune animals to transfer CMI to normal syngeneic animals was tested. Regional lymph nodes (popliteal, inguinal, and axillary), spleens, peritoneal exudate cells, and peripheral lymphocytes were collected from animals sensitized 14 days earlier.
The lymph nodes and spleens were cut into small pieces. The cells were then separated from the fibrous tissue by gentle pressing with a loosely fitted glass grinder, passed through a platinum sieve (mesh # 150), and washed with chilled Hanks' solution; the number of viable ceils was determined by the trypan blue dye exclusion method. For harvesting of peritoneal exudate cells, the animals received intraperitoneally (i.p.) 30 mi paraffin oil 11 days after sensitization. 3 days later, these animals were bled to death by heart puncture with a heparinized syringe and were then given 50 ml of cold Hanks' solution i.p. The middle of the abdomen was opened and the peritoneal fluids were carefully pipetted and transferred to a separating funnel to separate the paraffin oil from the cell-rich suspension, which was washed three times with Hanks' solution and resuspended in Eagle's minimal essential medium (MEM; Grand Island Biological Co., Grand Island, N.Y.). For collection of peripheral lymphocytes, the blood of these animals was mixed with one-fifth of its volume of 6% dextran (molec. wt. 250,000; Pharmaeia, Uppsala, Sweden) and the mixture was allowed to stand for 60-90 min. The upper portion of the cell suspension was transferred into glass culture bottles, which were incubated for 90 min at 37 ° C in a CO 2 incubator, each bottle being turned onto its other side after the first 45 min. The nonadherent blood lymphoeytes were then removed from the culture bottles, washed three times with chilled Hanks' solution and finally resuspended in MEM medium.
Antigen-Induced Stimulation opH-Thymidine Uptake by Sensitized
Lymphoid Cells. The in vitro stimulation of 3H-thymidine incorporation into the DNA of lymphoid cells of sensitized Gp 13 in the presence of the immunizing antigen was used to establish the degree of CMI. For this purpose, 2 × 106 lymphoid cells (from axillary, inguinal, and popliteal lymph nodes) of guinea-pig immune to goat IgG in 0.5 ml RPMI 1640 medium (Grand Island Biological Co., Grand Island, N.Y.) containing 10% fetal calf serum (FCS), were incubated in culture tubes with 0.5 mi goat IgG at several concentrations (1, 10, or 100 ~xg/ml) at 37 ° C in a CO 2 incubator. After 72 h, 1 ~xCi 3H-thymidine (6.7 Ci/mmol, New England Nuclear, Boston) was added to each culture tube and incubation was continued for a further 8 h. To remove free aH-thymidine, the cells were washed three times with cold phosphate-buffered saline (PBS) at pH 7.2. The DNA and proteins were precipitated with 5% trichloroacetic acid (TCA) after the addition of one drop of normal guinea-pig serum (this served as carrier proteins); the precipitate was washed twice with 5% TCA and once with cold ethanol, and was then dissolved in 1 ml Protosol (New England Nuclear, Boston) by incubating in a water bath for 2 h at 50 ° C. The solution was transferred to scintillation vials with I0 ml scintillator cocktail (6.0 g of PPO and 0.2 g of POPOP in 11 toluene) and the radioactivity of each vial was determined in a Mark II Liquid Scintillation Counter (Nuclear Chicago) at 4 ° C. The experiment was performed in triplicate and the results were corrected for efficiency and quenching. The results of these three tests were used to establish both the optimal time for harvesting sensitized cells from immune animals and the doses of sensized cells suitable for use in subsequent experiments.
Localization of 51Cr-labelled Sensitized Lymphoid Cells in Tumor-Bearing Gp 13
In order to test whether lymphoid cells of Gp 13 that had been sensitized to goat IgG really would 'home' to the MC-D sarcoma in tumor-bearing animals (after these animals had received goat AGFA i.v.), these cells were labelled with 5~Cr. The localization of these cells after adoptive transfer was established in the different organs of the tumor-bearing animals. For this purpose, lymphoid cells (pools of lymph nodes, spleens, and peritoneal exudates) of both sensitized and normal Gp 13 were labelled with 51Cr by the addition of 1 mCi 51Cr (Sodium chromate, Atomic Energy of Canada Ltd., Ottawa) to 5 x 109 cells in RPMI 1640 medium containing 10% FCS. The mixture was maintained for 30 rain at 37 ° C with occasional shaking. The labelled cells were then washed five times with Hanks' solution and their suspension was adjusted to 2 x l0 s cells/ml.
2 weeks after implantation of the MC-D cells, i.e., at a time when the tumor nodules were 1-2 cm in diameter, each of the test animals received 20 ~g N purified goat AGFA i.v. and the control animals received the same amount of goat IgG; this dose of AGFA was chosen because it had been shown previously that intravenous administration of 20 p~g N AGFA resulted in the localization of 70% of these antibodies within the tumor matrix (Lee et al., 1978) . In order to determine the most efficient route for localization of 51Cr-labelled lymphoid cells in the tumor site, 48 h after administration of AGFA each guinea-pig received 2 x l0 s of the labelled sensitized lymphoid cells i.v., i.p., or s.c. The recipients were sacrificed 24 h later by ether anesthesia, and their blood, lungs, hearts, livers, spleens, kidneys, and tumors were tested for 5~Cr content in a Nuclear Chicago F-ray counter; 1 g of each tissue was used for determi-nation of the radioactivity and the total radioactivity was then calculated for the whole tissue.
Experimental Design
To test the hypothesis underlying this project, the following experimental protocol was designed. Five groups of three to four adult, male and female, guinea-pigs (weight 400-500 g) received 106 tumor cells per animal s.c. in their backs 7 days before being subjected to immunological manipulation as described below. At this time, the tumor became palpable and its diameter was measured daily with a vernier caliper. Group I served as the control and was not subjected to any additional treatment; Group II received only the lymphoid cells sensitized to the rabbit or goat IgG; Group III received the rabbit or goat AGFA only; Group IV received both the rabbit or goat AGFA and lymphoid cells sensitized to the corresponding xenogeneic IgG; Group V received normal rabbit or goat IgG and lymphocytes sensitized to the corresponding IgG. The cells were injected s.c. within a few centimeters from the tumor sites since, as had been shown, this route was the most effective for localization of the cells within the tumor. The time intervals between injections of xenogeneic IgG and the adoptive transfer of cells and the type of cells transferred, will be indicated later.
The statistical significance of the differences in tumor size among different groups of guinea-pigs was established by Student's ttest. 
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Results
CMI in Gp 13 to Xenogeneic IgG
The results listed in the first section of Table 1 demonstrate that marked delayed hypersensitivity skin reactions were produced in guinea-pigs that had been sensitized to xenogeneic IgG when they were challenged with the immunizing antigen. Moreover, the data presented in the second section of this Table indicate that doses larger than 108 lymphoid cells of immune animals were required for passive transfer of marked skin reactions and, therefore, this was the minimum dose used in subsequent experiments. From the result given in the bottom section of this Table it is evident that increased 3H-thymidine uptake by lymphoid cells from immune animals occurred upon culture with the immunizing antigen, thus corroborating the in vivo findings that immunization of Gp 13 with a single dose (80 ~g) of rabbit or goat IgG in the presence of FCA was sufficient to induce a strong CMI, which was transferable with lymphoid cells.
Localization of 51Cr-Labelled Sensitized Lymphoid Cells in Gp 13 Bearing the MC-D Tumor
Forty-eight hours after i.v. injection of purified goat AGFA into tumor-bearing Gp 13, 51Cr-labelled sensitized lymphoid cells were transferred into these animals 
Testing of the Hypothesis for Indirect Cell-Mediated Tumor Destruction
A G F A and sensitized cells was about half that of the control guinea-pigs, and the tumors of the animals so treated were infiltrated with polymorphonuclear and mononuclear cells. Moreover, diffuse infiltration of tumor cells was found in the livers, spleens, and lymph nodes of these animals and diffuse millary necrotic lesions were detected in their organs and in the kidneys.
In another series of experiments, removal of adherent cells from pooled populations of spleen and lymph In a series of experiments, each of the tumor-bearing Gp 13 received only a single injection of 10 ~g N of rabbit AGFA, which was followed 2 days later by a single dose (8 x 108) of sensitized lymphoid cells consisting of a pool of cells from lymph nodes, peripheral blood, and peritoneal exudates of the immune animals. As is evident from the results plotted in Figure 1 , significant suppression of tumor growth (P < 0.01) was achieved in the animals that had received both A G F A and the sensitized cells. On the other hand, the tumor growth of animals that received only A G F A or only sensitized cells did not differ markedly from that of control animals, which had not received any treatment after implantation of the tumor. Similarly, the growth of the tumor was not affected by administration of normal xenogeneic IgG and cells from guinea-pigs that had been sensitized to a state of CMI to the corresponding IgG (data not plotted).
This experiment was terminated after 14 days of observation, when the animals were killed with ether anesthesia. The animals were then subjected to autopsy and several organs were examined histologically. The tumor diameter of control tumor-bearing animals at this time was larger than 5.5 cm and there was no detectable change in any of their organs. The size of the tumors of the animals treated with A G F A or sensitized cells approached that of controls; these two groups of animals did not show any significant change in their organs other than a somewhat enlarged spleen. In contrast, the size of tumors in the animals that had received both Results are expressed as means A standard deviations node cells of sensitized guinea-pigs and exclusion of the peritoneal exudate cells in the cell transfer appeared to result in the abrogation of the retardation effect of sensitized lymphoid cells on tumor growth. All animals succumbed to the tumor growing locally and no tumor cells were found in other organs.
In a third series of experiments the effects of multiple injections of AGFA and of the peritoneal exudate cells of sensitized animals was evaluated. For this purpose all animals received three i.v. injections of 20 ~g N of purified AGFA (i.e., total 60 p~g N) on days 7, 12, and 16 after implantation of tumor cells. One group of animals received 5 x 108 lymphocytes on each of days 8, 13, and 17 from a pool of cells obtained from spleens, lymph nodes and peripheral blood of sensitized guineapigs. Another group received the same number of cells on the same days, except that the pool of cells also contained peritoneal exudate cells.
As is evident from the data plotted in Figure 2 , in the absence of peritoneal exudate cells there was no significant retardation of tumor growth. However, the inclusion of peritoneal cells among the lymphoid cell population in the adoptive transfer resulted in a considerable slowing down of tumor growth (P < 0.05). These results thus confirm the finding illustrated in Figure 1 . Nev- ertheless, in spite of the lower rate of tumor growth in animals that had received both AGFA and sensitized cells, these animals succumbed to the tumor and their survival time did not differ significantly from that of control animals, probably due to enhanced metastasis caused by tumor cells emigrating from the tumor foci to the other organs.
Discussion
It is obvious that this in vivo study is by no means complete and that the data obtained to date are based on a relatively small number of experiments. One of the main limitations of this model was the unavailability of inbred guinea-pigs in the numbers necessary for the relatively large number of lymphoid cells required in these experiments; thus, eight to ten sensitized guinea-pigs provided the lymphoid cells for three to four experimental tumor-bearing hosts.
The observation that the growth of the MC-D sarcoma was significantly retarded in animals that had received both AGFA and lymphoid cells from syngeneic guinea-pigs that had been sensitized to immunoglobulins isotypic with AGFA, but not with either AGFA or lymphoid cells alone, is interpreted as being due to the local inflammatory reaction triggered by the sensitized cells on interaction with the AGFA-coated fibrin matrix present in the tumor foci. Moreover, the fact that deletion of peritoneal exudate cells from the pool of sensitized lymphocytes resulted in loss of the capacity of these cells to suppress tumor growth suggests that peritoneal cells may be essential for the success of this type of immunological maneuver, which leads to an indirect cell-mediated destruction of malignant cells. Since peritoneal exudate cells are usually rich in macrophages, it may be speculated that these phagocytic cells played a significant part in the observed suppression of tumor growth. The evidence that macrophages have been shown to home to the site of delayed hypersensitivity reaction (Boughton and Spector, 1963) can be cited in support of this inference.
Before any definite conclusion can be drawn as to the nature of the cells involved in tumor rejection in this model system, it well be necessary to repeat these experiments with well-defined subpopulations of lymphoid cells from guinea-pigs sensitized to the antigenic determinants of AGFA. Nevertheless, these results lend further support to the concept that tumor cells may be destroyed as a result of CMI to antigenic determinants of constituents present in tumor foci other than tumor antigens per se. On this point one may also cite the results of Williams and Klein (1970) who reported successful eradication of cutaneous malignancies in over 50 patients in whom cell-mediated hypersensitivity to sim-200 F. H. Lee et al.: Use of Antifibrin Antibodies for Destruction of Tumor Cells. II pie contact-sensitizing chemicals, such as trenimon or dinitrochlorobenzene, was induced actively or passively, provided that these substances could penetrate into the neoplastic area. Moreover, Zbar et al. (1970) had demonstrated that proliferation of a transplantable tumor in inbred guinea-pigs was suppressed both at the sites of delayed hypersensitivity skin reactions to another antigenically different transplantable tumor and at the sites of delayed hypersensitivity skin reactions to tuberculoproteins, and that the effectiveness of the immunologically nonspecific killing of tumor cells was directly related to the intensity of the delayed hypersensitivity reaction. The same group of workers (Zbar and Tanaka, 1971 ) also showed that tumor nodules in guinea-pigs regressed at the site of inflammatory reactions provoked by living Mycobacterium boris.
The findings in this study that the tumor size in animals treated with both A G F A and sensitized lymphocytes was smaller than that in controls, and that the organs of the former animals were infiltrated with tumor cells, are interpreted as being due to the local inflammatory reaction resulting not only in tumor cell destruction, but also in disorganization of the fibrin lattice, allowing thus for the escape of tumor cells to other sites. However, it is important to point out that whereas in the present study injection of A G F A by itself did not affect the growth of the tumor, Schlager and Dray (1975) reported recently that complete tumor regression was achieved with subcutaneous injection of antibodies to fibrin fragment E to guinea-pigs bearing a line-10 hepatoma that had been implanted intradermally into strain 2 guinea-pigs. Since the tumors and the experimental conditions used in these two studies are different, it is not possible to draw any conclusion as to the reason for the diverging effects of antibodies to the constituents of fibrin.
In spite of the limited number of results, it can be stated that the findings presented in this paper support the validity of the working hypothesis underlying this study. It appears, therefore, that the principle of indirect cell-mediated destruction of tumor cell represents a promising immunotherapeutic strategy, which involves the accumulation of sensitized lymphocytes in the tumor foci, which are thus converted into battlegrounds unfavorable to the support of further growth of tumor cells.
